Site reference ID 204 — Loxahatchee Groves, Florida

Site reference ID 204 is a clinical research site located in Loxahatchee Groves, Florida, United States 33470.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Site reference ID 204 has participated in 1 clinical trials.

Therapeutic areas: Uterine Fibroids, Heavy Menstrual Bleeding.

Sponsors: ObsEva SA.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Loxahatchee Groves

Browse all research sites in Florida · View every site in Loxahatchee Groves

• Palms West Hospital
• Axcess Medical Research
• Advanced Pulmonary Research Institute
• Palms West Radiation Therapy
• GSK Investigational Site
• Research Site
• Loxahatchee
• Hematology Oncology Associates
• Pediatric Neurology and Epilepsy Center
• Novartis Investigative Site
• Family Arthritis Center
• Pulmonary Specialists of The Palm Beaches

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Site reference ID 204?

Site reference ID 204 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Site reference ID 204 conducted?

Site reference ID 204 has 1 clinical trials on record. Their work covers Uterine Fibroids, Heavy Menstrual Bleeding.

Is Site reference ID 204 accredited by Crixeo Clinical Trials?

Site reference ID 204 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Site reference ID 204?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.